Mesa Laboratories, Inc. (MLAB) Earnings History
Growth Compounder37 years of earnings data (1990–2026) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
Mesa Laboratories, Inc. (MLAB) Earnings Overview
As of July 8, 2026, Mesa Laboratories, Inc. (MLAB) reported trailing twelve-month net income of $7M, reflecting +436.1% year-over-year growth. The company earned $1.21 per diluted share over the past four quarters, with a net profit margin of 2.7%.
Looking at the long-term picture, MLAB's 5-year EPS compound annual growth rate (CAGR) stands at +13.6%, showing solid earnings momentum. The company achieved its highest annual net income of $11M in fiscal 2017.
Mesa Laboratories, Inc. maintains positive profitability with a gross margin of 63.5%, operating margin of 7.4%, and net margin of 2.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including NEOG (-$609M net income, -122.1% margin), LFUS (-$40M net income, -3.0% margin), NOVT ($54M net income, 5.5% margin), MLAB has outperformed on profitability metrics. Compare MLAB vs NEOG →
MLAB Earnings vs Peers
Earnings metrics vs comparable public companies
MLAB Historical Earnings Data (1990–2026)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | $7M | +440.0% | $19M | $1.21 | 2.7% | 7.4% |
| 2025 | -$2M | +99.2% | $16M | $-0.36 | -0.8% | 6.8% |
| 2024 | -$254M | -27438.3% | -$272M | $-47.20 | -117.6% | -125.9% |
| 2023 | $930,000 | -50.3% | $3M | $0.17 | 0.4% | 1.5% |
| 2022 | $2M | -42.9% | $5M | $0.35 | 1.0% | 2.6% |
| 2021 | $3M | +84.1% | $12M | $0.64 | 2.4% | 9.2% |
| 2020 | $2M | -76.2% | $8M | $0.31 | 1.5% | 6.7% |
| 2019 | $7M | +352.7% | $10M | $1.86 | 7.3% | 9.5% |
| 2018 | -$3M | -126.5% | $2M | $-0.79 | -3.1% | 2.3% |
| 2017 | $11M | +0.1% | $16M | $2.91 | 11.9% | 17.4% |
| 2016 | $11M | +16.6% | $16M | $2.97 | 13.2% | 19.3% |
| 2015 | $10M | +6.5% | $16M | $2.63 | 13.4% | 22.2% |
| 2014 | $9M | +6.5% | $12M | $2.49 | 17.1% | 22.4% |
| 2013 | $8M | +6.7% | $13M | $2.35 | 18.2% | 28.2% |
| 2012 | $8M | +28.1% | $12M | $2.29 | 20.0% | 31.5% |
| 2011 | $6M | +29.6% | $10M | $1.86 | 18.8% | 30.0% |
| 2010 | $5M | -0.4% | $7M | $1.45 | 21.7% | 33.6% |
| 2009 | $5M | +3.9% | $8M | $1.48 | 22.2% | 35.3% |
| 2008 | $5M | +16.5% | $7M | $1.41 | 23.6% | 36.1% |
| 2007 | $4M | +41.1% | $6M | $1.22 | 23.0% | 32.8% |
| 2006 | $3M | +21.3% | $4M | $0.92 | 24.2% | 35.5% |
| 2005 | $2M | +8.5% | $3M | $0.74 | 23.0% | 34.6% |
| 2004 | $2M | +0.1% | $3M | $0.68 | 23.3% | 35.6% |
| 2003 | $2M | +4.7% | $3M | $0.64 | 23.4% | 35.1% |
| 2002 | $2M | +10.8% | $3M | $0.59 | 22.5% | 32.5% |
| 2001 | $2M | -13.0% | $3M | $0.59 | 20.1% | 30.8% |
| 2000 | $2M | +0.3% | $3M | $0.55 | 24.3% | 32.9% |
| 1999 | $2M | +0.0% | $3M | $0.50 | 25.9% | 38.3% |
| 1998 | $2M | +23.5% | $3M | $0.47 | 26.6% | 35.4% |
| 1997 | $2M | +6.3% | $3M | $0.39 | 21.8% | 32.1% |
| 1996 | $2M | +33.3% | $2M | $0.29 | 19.8% | 29.6% |
| 1995 | $1M | +20.0% | $2M | $0.29 | 18.2% | 28.8% |
| 1994 | $1M | +11.1% | $2M | $0.23 | 16.1% | 25.8% |
| 1993 | $900,000 | +0.0% | $1M | $0.21 | 20.5% | 29.5% |
| 1992 | $900,000 | +0.0% | $1M | $0.21 | 23.7% | 31.6% |
| 1991 | $900,000 | +125.0% | $900,000 | $0.20 | 25.7% | 25.7% |
| 1990 | $400,000 | - | $500,000 | $0.10 | 14.3% | 17.9% |
Download Data
Export MLAB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
36+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MLAB — Frequently Asked Questions
Quick answers to the most common questions about buying MLAB stock.
What is MLAB earnings per share (EPS)?
MLAB trailing twelve-month (TTM) diluted EPS is $1.21, reflecting +436.1% year-over-year growth. The 5-year EPS CAGR is +13.6%. Complete EPS history from 1990 to 2026 is available in the table on this page.
What is Mesa Laboratories, Inc.'s net income?
Mesa Laboratories, Inc. (MLAB) trailing twelve-month net income is $7M as of 2026. Earnings grew +436.1% year-over-year.
Is MLAB profitable?
Yes, MLAB is profitable with a TTM net income of $7M and a net profit margin of +2.7%.
What is MLAB's earnings growth rate?
MLAB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: +92.4%, 5-Year: +13.6%, 10-Year: -8.6%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1990 to 2026.
What are MLAB's profit margins?
Mesa Laboratories, Inc. net profit margin is +2.7%, operating margin is +7.4%, and gross margin is +63.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is +3.9%.
Is MLAB growing earnings?
Yes, MLAB earnings are accelerating — EPS growth of +436.1% exceeds the 5-year CAGR of +13.6%. TTM net income reached $7M. Earnings momentum is strengthening.
What was MLAB's best earnings year?
Mesa Laboratories, Inc.'s highest annual net income on record is $11M, achieved in fiscal year 2017. Earnings history on this page spans 1990 to 2026 and includes all annual and quarterly figures.
What were MLAB's earnings last quarter?
MLAB's most recent reported quarter was Q4 2026. Net income was $-4M with diluted EPS of $-0.75. For a full breakdown of all quarters, see the quarterly earnings table on this page.